Searchable abstracts of presentations at key conferences in endocrinology

ea0030p51 | (1) | BSPED2012

Growth and glucose homeostasis after 2 years in children with inflammatory bowel disease receiving recombinant GH therapy for growth retardation

Towati Mabrouka A L , Wong S C , Galloway P J , Hassan K , Russell R K , McGrogan P , Ahmed S F

Background: A recent RCT of rhGH in IBD over 6 months showed that improvement in linear growth was associated with a reduction in insulin sensitivity.Objectives: To investigate the effects of prolonged rhGH on growth and glucose homeostasis in children with IBD.Patients and methods: Eleven children (10CD/1UC) (9 m) with a median age of 14.7 years (range, 8.9, 16.2) who received rhGH (0.067 mg/kg per day) as part a 6-month RCT were ...

ea0026p284 | Pituitary | ECE2011

Improvement in clinical signs and symptoms of Cushing’s disease following 12 months' pasireotide therapy

Pivonello R , Newell-Price J , Findling J W , Gu F , Maldonado M , Schoenherr U , Mills D , Salgado L R , Biller B M K

Introduction: The multi-receptor targeted somatostatin analogue pasireotide has demonstrated efficacy in reducing cortisol in patients with Cushing’s disease in a large, randomized, double-blind, Phase III study. The effects of pasireotide on the signs and symptoms of Cushing’s disease were also investigated as secondary objectives in this trial.Methods: Adult patients with persistent/recurrent or de novo Cushing’s disease were rand...

ea0077op5.1 | Bone and Calcium | SFEBES2021

Parathyroid hormone (PTH) of 1.6 pmol/l or more at 6 months is associated with delayed recovery of parathyroid function in post-surgical hypoparathyroidism (PoSH)

Fahad Arshad Muhammad , Dhami Amardass , Quarrell Gillian , Balasubramanian Saba P

Introduction: Post-surgical hypoparathyroidism (PoSH) is common after thyroidectomy. Most cases recover within 6 months, but several require long-term supplementation with calcium and activated vitamin D. When PoSH persists beyond 6 months, it is considered to be ‘long-term’ or ‘permanent’. However, few studies have demonstrated recovery beyond this time period.Aim: Aim of this study is to determine the frequency of late recovery in t...

ea0020p238 | Bone/Calcium | ECE2009

Evaluation of the association between bone turnover markers and OPG/sRANK-L levels in relation with the changes of thyroid function in women with thyroid cancer

Salman Serpil , Aral Ferihan , Boztepe Harika , Colak Nese , Omer Beyhan , Tanakol Refik , Alagol Faruk , Kabut-Uzum Ayse

Aim: Thyroid hormones play an important role in bone remodeling. The aim of the study was to evaluate the changes of bone markers and osteoprotegerin (OPG)/sRANK-L levels during follow-up in a group of patients with thyroid cancer.Material and methods: Twenty euthyroid women with the diagnosis of differentiated thyroid cancer were enrolled to the study (39.25±13.46 years, 6 postmenopausal) before thyroidectomy. Samples were collected before the oper...

ea0003p48 | Clinical Case Reports | BES2002

Multidisciplinary management of Cushing's syndrome due to a malignant thymic carcinoid tumour

Park C , Watson W , Abraham P , Acharya S , Bandyopadhyay S , Philip S , Samuel L , Nicolson M , Bevan J

Thymic carcinoma is a rare but aggressive cause of ectopic ACTH secretion, with fewer than 100 reported cases.Hypokalaemic alkalosis was found in a 38 year old woman who presented with a 2-week history of leg swelling, fatigue and dyspnoea. She was not obviously Cushingoid.ACTH-dependent Cushing's Syndrome was confirmed biochemically: urinary free cortisol (UFC) >8500nmol/day and serum cortisol 4060nmol/l, (no suppression on 8...

ea0029p618 | Diabetes | ICEECE2012

Changes of NO concentration in the cause of streptozotocin diabetes mellitus and under action of different NOS inhibitors in streptozotocin rats

Sokolovska J. , Sharipova J. , Lauberte L. , Baumane L. , Kalvins I. , Sjakste N.

Background: Diabetes mellitus (DM) and its complications cause numerous health and social problems throughout the world. Pathogenic action of nitric oxide (NO) is responsible to a large extent for development of complications of the disease. Thus modification of NO production in DM patients appears to be an option for treatment of DM complications.Objective: To study changes in NO concentration in diabetic rats after administration of different compounds...

ea0090p602 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Effect of Origanum vulgare L. essential oil on insulin-induced PI3K/Akt signaling and glucose uptake in human adipocytes treated with palmitic acid

Cerda Alexis , Yuri Gabriela , Villagran Isidora , Muller Andrea , Foerster Claudia , Ormazabal Paulina

Background: Obesity is strongly associated with insulin resistance (IR). IR at the molecular level may be defined as a diminished activation of PI3K/Akt signaling and its related molecules (IRS-1/Akt/AS160) as well as reduced glucose uptake. Subjects with obesity have elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which triggers insulin signaling disruption in vivo and in vitro. Oregano (Origanum vulgare L.) is a plant u...

ea0057031 | TSH receptor-blocking autoantibodies: the pregnancy paradigm | BES2018

TSH receptor-blocking autoantibodies: the pregnancy paradigm

Martens P-J , Polders C , Decallonne B

Background: Graves’ disease (GD) is an autoimmune disease caused by antibodies directed to the TSH receptor (TRAb), which can be activating (TSAb), neutral, or blocking (TBAb). This balance determines the final clinical result. Typically TSAbs dominate, resulting in hyperthyroidism. Rarely, TBAbs prevail and result in hypothyroidism (1). The TRAb assay routinely used in the clinic does not allow to differentiate between stimulating or blocking characteristics.<p class...

ea0029p1290 | Paediatric endocrinology | ICEECE2012

Noonan syndrome: short stature and pubertal delay

Alves M. , Barreiro J. , Heredia C. , Cabanas P. , Castro-Feijoo L. , Bastos M. , Carvalheiro M. , Pombo M.

Background: Noonan syndrome (NS) is a relatively common disease, clinically and genetically heterogeneous. It is characterized by facial dysmorphia, growth retardation, congenital heart disease, lymphatic dysplasia, among others. The diagnosis is clinical, according to van der Burgt criteria. In 61% of cases genetic mutations in the signaling pathway of RAS-MAPK are identified.Clinical case: BVM, male, NS suspected. At 3 years old sent to Pediatric Endoc...

ea0038p5 | Bone | SFEBES2015

Soy protein with isoflavones reduce bone turnover markers in women during their early menopause – a randomised double blind parallel study

Sathyapalan Thozhukat , Aye Mo , Kilpatrick Eric S , Rigby Alan S , Fraser William D , Thatcher Natalie J , Atkin Stephen L

Importance: The major factor contributing to the high incidence of osteoporosis in older women is the reduction in estrogen synthesis. Isoflavones have a similar structure to 17-β estradiol and can act as selective estrogen receptor modulators.Objective: To determine the safety and effect of soy isoflavones on bone during early menopause.Design: Parallel, double blind, study.Setting: Secondary care resea...